Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial
Yet, a significant change was seen in the fasting blood sugar level before and by the end of the study in the intervention group
BioWorld - Sunday, July 26, 2026 See today's BioWorld Home Pfizer M&A prospect Metsera heads to phase III with lead GLP-1 To read the full story, subscribe or sign in
Best candidates for tirzepatide Tirzepatide is the stronger choice for researchers who: Want a proven, FDA-approved compound with extensive safety data Need reliable, consistent access through established supply chains Prefer multiple administration options (injectable, oral drops , tablets ) Have lower side effect tolerance and want a more predictable GI experience Are achieving satisfactory weight loss goals (15-22% range) Want insurance coverage possibilities Are new to GLP-1 agonist therapy and want to start with the established option Need to travel with their medication and want pharmacy accessibility The practical advantages of tirzepatide cannot be overstated for many researchers
10.1016/j.diff.2020.11.002 28 CostaM